To Investigate the Safety and Tolerability of TC-5214 Following Oral Administration of Multiple Doses for up to 8 Days
Clinical trial NCT01145768 · COMPLETED
Trial details
- NCT number
- NCT01145768
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2010-08-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.